The CD44high Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression

PLoS ONE - United States
doi 10.1371/journal.pone.0073195
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

miR-34a Expression in Human Breast Cancer Is Associated With Drug Resistance

Oncotarget
Oncology
2017English

miR-497 and miR-34a Retard Lung Cancer Growth by Co-Inhibiting Cyclin E1 (CCNE1)

Oncotarget
Oncology
2015English

MicroRNA-34a (miR-34a)

Science-Business eXchange
2011English

The Low Expression of miR-451 Predicts a Worse Prognosis in Non-Small Cell Lung Cancer Cases

PLoS ONE
Multidisciplinary
2017English

Mechanism Research of miR‐34a Regulates Axl in Non‐small‐cell Lung Cancer With Gefitinib‐acquired Resistance

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

ZEB1 Drives Prometastatic Actin Cytoskeletal Remodeling by Downregulating miR-34a Expression

Journal of Clinical Investigation
Medicine
2012English

Predictive Relevance of miR‑34a, miR‑224 and miR‑342 in Patients With Advanced Squamous Cell Carcinoma of the Lung Undergoing Palliative Chemotherapy

Oncology Letters
Cancer ResearchOncology
2017English

High Expression of miR-155 and miR-21 in the Recurrence or Metastasis of Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Figure 6: Quantitative PCR Analysis of miR-26a-5p, miR-181a-5p, miR-34a-5p, miR-93-5p, Pten, Creb, BCL-2, and Sirt1 Expression in miR-26a-5p (A), miR-181a-5p (B), miR-34a-5p (C), miR-93-5p (D) Mimic Transfected HUVECs.

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy